Clinical Trial Update: Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration [Phase 2]

View source ↗

Summary

This entry provides a status update on a Phase 2 clinical trial evaluating intravitreal microplasmin to relieve vitreomacular adhesion in neovascular age-relate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• intravitreal microplasmin (microplasmin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Macular Degeneration | Phase 2 | Status: UNKNOWN